Arena Oncology Associates, PC

Lake Success, New York 11042

0 studies enrolling now · 11 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Breast Neoplasms, Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Multiple Myeloma, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer

Studies at this site

• Connect® MM- The Multiple Myeloma Disease Registry — Stopped early
• A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed
• Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed
• Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer — Completed
• Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer — Completed
• Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer — Completed
• An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer — Stopped early
• Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer — Stopped early
• An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer — Completed
• A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) — Completed